![Can Cbd Gummies Make You Test Positive For A Drug Test? [KZEJU5Z7uSj]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/08/ced-pexels-28153356.jpg?resize=150%2C150&ssl=1 "Can Cbd Gummies Make You Test Positive For A Drug Test? 19")
| Audience | Patients, caregivers, clinicians, and cannabis-science readers interested in adolescent cannabis use and prevention |
| Primary Topic | adolescent cannabis quit attempts compared with nicotine vaping and cigarette quit attempts |
| Source | Read the full source |
Adolescent Cannabis Quit Attempts Lag Behind Tobacco
Among 25,930 California adolescents reporting past-month cannabis, nicotine-vape, or cigarette use, 38.7% of cannabis users reported a past-year quit attempt. The comparable rates were 52.9% for vaping and 47.7% for cigarettes. The survey analysis links quit attempts with perceived harm but does not establish why individual adolescents did or did not try to quit.
| Study Type | Cross-sectional analysis of the 2019 to 2020 California Student Tobacco Survey |
| Survey Population | 162,675 middle and high school students |
| Analytic Sample | 25,930 adolescents reporting past-month cannabis, nicotine-vape, or cigarette use |
| Primary Measure | Self-reported past-year quit attempt for each product used |
| Cannabis Quit Attempts | 38.7% |
| Nicotine-Vape Quit Attempts | 52.9% |
| Cigarette Quit Attempts | 47.7% |
| Risk Perception | Perceived harm predicted quit attempts across cannabis, vaping, and cigarettes |
| Product Comparison | Cannabis was perceived as the least harmful of the three products |
| Age Finding | Older age predicted fewer cannabis quit attempts, but not fewer vaping or cigarette quit attempts |
| Gender Finding | The abstract reports no gender differences in quit-attempt rates for any of the three products |
| Primary Boundary | The analysis identifies associations and cannot establish the reason for individual quit behavior |
| Published | September 8, 2026 |
| PMID | 42731276 |
| DOI | 10.1016/j.drugalcdep.2026.113356 |
Within the 25,930 adolescents reporting past-month use of at least one studied product, 38.7% of cannabis users reported a past-year quit attempt. The rate was 52.9% among nicotine-vape users and 47.7% among cigarette users.
The cannabis difference was statistically significant compared with both tobacco-product groups. The abstract reports no statistically significant difference between vaping and cigarette quit-attempt rates.
Perceived harm consistently predicted quit attempts across cannabis, nicotine vaping, and cigarettes. Cannabis was also perceived as the least harmful of the three products in this survey population.
That association is clinically relevant, but it is not proof that a risk message will produce a quit attempt. The authors state that perceptions and social norms may partly contribute and should be considered in prevention work.
Older age predicted fewer cannabis quit attempts, while the abstract did not report the same age pattern for vaping or cigarettes. Race and ethnicity patterns varied by product, and parental education was negatively associated with quit attempts only for cannabis.
These findings argue against treating all adolescent substance use as one behavior. They do not establish a biological or social mechanism, and the abstract does not provide enough detail for individualized subgroup conclusions.
The source describes a survey analysis rather than a treatment or prevention trial. It does not show whether a quit attempt led to abstinence, reduced use, relapse, treatment engagement, or a change in cannabis use disorder symptoms.
Full text was not openly available for this review. Unreported questionnaire details, response patterns, model specifications, missing-data handling, and additional subgroup analyses were therefore not used in the article.
Adolescent counseling can miss a useful middle ground when it asks only whether cannabis is used. Asking whether a young person has wanted to cut down, tried to stop, or noticed problems can open a more specific discussion about motivation and support.
Risk communication should remain accurate and proportionate. Exaggerated claims can erode trust, while silence can leave adolescents to interpret lower perceived harm as absence of risk. The study supports attention to perception without prescribing one message or program.
The clinically useful signal is not that adolescents lack concern. It is that quit behavior differs across products, and cannabis may occupy a distinct place in how young people weigh risk, norms, and reasons to change.
I would ask about goals before delivering a lecture. Frequency, context, co-use, impairment, school function, mood, sleep, driving, and prior quit experiences can turn a broad prevention message into a safer and more respectful conversation.
How to Interpret This Adolescent Cannabis Quit Attempts Compared With Nicotine Vaping And Cigarette Quit Attempts Evidence Without Overstating It
A useful evidence report should let the signal breathe without inflating it.
The right question is not whether the paper is positive or negative, but what kind of decision it can responsibly support.
A Four-Step Reading Frame
Evidence type
Start by identifying whether the paper is a randomized trial, review, meta-analysis, observational study, or protocol.
Population
Ask whether the studied population matches the patient or clinical scenario involving adolescent cannabis use and prevention.
Outcome meaning
Look at what actually changed, how it was measured, and whether the change would matter in daily life.
Safety and uncertainty
Read limitations and adverse effects as part of the result, not as a footnote.
Eight Ways to Read the Adolescent Quit-Attempt Gap
Clinical, family, prevention, methods, safety, equity, and research perspectives
A Quit Attempt Is a Health Signal, Not a Moral Verdict
The survey found that adolescents who used cannabis were less likely to report a past-year quit attempt than peers who vaped nicotine or smoked cigarettes. That difference does not reveal what any one teenager wants, whether use is occasional or frequent, or whether a prior attempt felt successful.
A confidential conversation can begin with goals: stopping, cutting back, avoiding use before school or driving, or understanding effects on mood and sleep. The study does not test a counseling method, but it supports asking about motivation directly instead of assuming that cannabis users are either unconcerned or ready to quit.
Screen for Motivation Alongside Frequency and Harm
The same-survey comparison gives clinicians a reason to ask about quit attempts across cannabis, vaping, and cigarettes rather than grouping all products together. Past attempts can reveal motivation, triggers, withdrawal concerns, and places where practical support has been missing.
Assessment should also include frequency, potency when known, co-use, impaired driving, school function, mood, anxiety, sleep, and symptoms consistent with cannabis use disorder. The abstract does not validate a screening instrument or intervention, so the finding should shape inquiry, not create a new diagnostic shortcut.
A Large Sample Strengthens Precision, Not Causal Inference
The researchers analyzed 25,930 past-month users drawn from 162,675 California middle and high school students. Cannabis, vaping, and cigarette quit attempts were assessed within the same survey, addressing a comparability problem in earlier studies that used different samples or measures.
The design remains cross-sectional and self-reported. It can show that perceived harm and quit attempts were associated, but not which came first or whether another factor shaped both. The unavailable full text also prevents independent review here of questionnaire wording, missing data, and complete model specifications.
Lower Perceived Harm Should Not Be Read as No Harm
Cannabis was perceived as the least harmful of the three products, and perceived harm predicted quit attempts across all products. The study does not measure comparative toxicity, so the perception result cannot rank the actual health burden of cannabis, vaping, and cigarettes.
Safety discussions should be specific to developmental stage and behavior. Important topics can include intoxication, driving, high-potency exposure, anxiety or psychotic symptoms, school impairment, medication interactions, and progression toward problematic use. Accurate language matters because exaggeration can undermine the trust needed for disclosure.
Curiosity Can Preserve Communication
Parents and caregivers may interpret a lack of quit attempts as defiance or denial. The study cannot identify an individual adolescent’s reasons, and its findings leave room for perceived harm, social norms, product availability, dependence, stress, and other factors to differ from person to person.
Open questions are more likely to produce useful information: What does cannabis do for you? What problems have you noticed? Have you tried to change? What made that easier or harder? Safety boundaries remain important, especially around driving and younger siblings, but they work best alongside listening and access to confidential clinical support.
One Message May Not Fit Three Products
Quit-attempt rates and demographic patterns differed across cannabis, nicotine vaping, and cigarettes. That suggests adolescents may interpret each product through a different mix of risk beliefs and social norms, even when they use more than one product.
Prevention programs can acknowledge those differences while avoiding unsupported promises. This paper does not test a campaign, school program, or clinical intervention. Its contribution is to identify perceptions and quitting behavior as targets for future study, with enough product specificity to avoid treating every form of substance use as interchangeable.
Subgroup Patterns Need Context Before Action
The abstract reports that race and ethnicity patterns varied across products, while parental education was negatively associated with quit attempts only for cannabis. Those findings may reflect differences in norms, access, exposure, enforcement, stress, or survey context, but the abstract does not establish an explanation.
Programs should resist turning demographic associations into stereotypes. Community input, culturally responsive communication, confidential care, and attention to unequal disciplinary consequences can help prevention efforts support adolescents rather than intensify surveillance. Full subgroup estimates and methods would be needed before drawing narrower conclusions.
Follow Quit Attempts Through Outcomes
The next step is longitudinal research that distinguishes desire to quit, planning, attempts, reduced use, sustained abstinence, relapse, and treatment engagement. Repeated measures could help clarify whether perceived harm predicts later change or whether quitting experiences reshape perceived harm.
Intervention studies should compare accurate product-specific education, motivational approaches, family support, digital tools, and clinical referral pathways. Outcomes should include cannabis and nicotine use, functioning, mental health, driving risk, and unintended effects such as stigma or reduced disclosure. Co-use deserves explicit analysis because many adolescents use more than one product.
Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan
Want to discuss this topic with other patients and caregivers? Join the forum discussion
Frequently Asked Questions
What survey did the researchers analyze?
They analyzed the 2019 to 2020 California Student Tobacco Survey of 162,675 middle and high school students.
How many adolescents were included in the product-use analysis?
The analytic sample included 25,930 adolescents reporting past-month cannabis, nicotine-vape, or cigarette use.
How common were cannabis quit attempts?
Among adolescents who used cannabis, 38.7% reported a past-year quit attempt.
How did that compare with nicotine products?
Past-year quit attempts were reported by 52.9% of nicotine-vape users and 47.7% of cigarette users.
Did vaping and cigarette quit-attempt rates differ?
The abstract reports no statistically significant difference between the vaping and cigarette rates.
What role did perceived harm play?
Higher perceived harm predicted quit attempts across cannabis, nicotine vaping, and cigarettes, and cannabis was perceived as the least harmful product.
Does the study prove that lower risk perception caused fewer cannabis quit attempts?
No. The survey analysis found an association, but it cannot establish causal direction or explain every adolescent's motivation.
Did the study measure successful quitting?
The abstract reports past-year quit attempts. It does not report sustained abstinence, relapse, or treatment outcomes.
Was the full article available for this review?
No. The peer-reviewed PubMed abstract and identifier record were reviewed, so study-specific claims are limited to information reported there.
What is the practical takeaway for families and clinicians?
Ask adolescents directly and without judgment about goals, prior quit attempts, perceived risks, co-use, functioning, and what support they would accept.
